Dealing with biologics production uncertainty

To better understand demand forecasting challenges, a survey of pharmaceutical and biotechnology industry leaders from North America and Europe was conducted by business intelligence firm ORC International and sponsored by Patheon, a leading global provider of high-quality drug development and […]

Read More

Specialty pharma becomes ‘hub enabled’

In this issue, we return to a topic we’ve covered annually since 2013: hub services. A definition: hub services are usually third-party providers, funded by manufacturers themselves, delivering the range of services necessary to get patients onto specialized (and usually […]

Read More